Raid Aljumaily to Response Evaluation Criteria in Solid Tumors
This is a "connection" page, showing publications Raid Aljumaily has written about Response Evaluation Criteria in Solid Tumors.
Connection Strength
0.046
-
Immunologic and tumor responses of pegilodecakin with 5-FU/LV and oxaliplatin (FOLFOX) in pancreatic ductal adenocarcinoma (PDAC). Invest New Drugs. 2021 02; 39(1):182-192.
Score: 0.046
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.